The percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market is estimated to be valued at US$ 2.2 Billion in 2022 and is expected to exhibit a CAGR of 8 % over the forecast period (2022-2030)
Figure 1. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Value (US$ Mn), By Region, 2022
Market Trends: Increasing cardiovascular disease epidemiology worldwide is expected to boost the percutaneous transluminal coronary angioplasty (PTCA) market growth over the forecast period.
For instance, according to the data published in the Centers for Disease Control and Prevention in 2020, in the year 2020, about 20.1 million adults age 20 and older had cardiovascular diseases (about 7.2%), and about 2 in 10 deaths from cardiovascular diseases happened in adults less than 65 years old in U.S.
Figure 2. Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market Share (%), By Product Type, 2022
Increasing product launches and approvals are expected to drive the growth of the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market over the forecast period.
For instance, in July 2021, MedAlliance, a medical technology company headquartered in Switzerland, had launched ORIGIN NC, two high-performance balloons for vessel preparation. ORIGIN SC is a semi-compliant (SC) PTCA with a very low crossing profile. Its sizes include 1.00 mm, 1.25 mm, 1.50 mm, and 1.75 mm balloon diameter to treat very small vessels and complex cases.
ORIGIN NC is a non-compliant (NC) PTCA balloon, combining high-pressure tolerance and controlled compliance with an optimal crossing profile for challenging cases.
Moreover, in August 2018, S3V Vascular Technologies Private Limited, a medical devices manufacturing company, launched Nextgen PTCA (Percutaneous Transluminal Coronary Angioplasty) Balloon Catheters.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients